Trials / Completed
CompletedNCT00966745
Milrinone During Living Donor Hepatectomy
Effect of Milrinone During Living Donor Hepatectomy Using a Low Central Venous Pressure Technique
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Maintaining a low central venous pressure during living donor hepatectomy is routine practice. The investigators tried to test the hypothesis that using milrinone to maintain a low central venous pressure (CVP) during is associated with a superior surgical field and less blood loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | milrinone | |
| DRUG | placebo |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2009-08-27
- Last updated
- 2009-08-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00966745. Inclusion in this directory is not an endorsement.